Rare disease biotech picks up $8M, drug development partner for DNA-based therapies
December 31, 2013 2:16 pm by Deanna Pogorelc | 0 Comments, medcitynews.com

A biotech focus­ing on DNA-based ther­a­pies for Friedre­ich’s atax­ia raised $8 mil­lion and found a part­ner for rare dis­ease drug devel­op­ment.

<p>Amid some­what of a renais­sance in drug devel­op …

Rare disease biotech picks up $8M, drug development partner for DNA-based therapies | @scoopit http://flip.it/CGfCT…@myhealthshare

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s